Skip to main content

Table 1 Baseline characteristics of mothers

From: Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation

Characteristics of mothers

Telbivudine group

(N = 139)

Control group

(N = 102)

P value

Age, years, median (range)

26 (20–43)

26 (18–42)

0.061

Prior pregnancy, median (range)

1 (1–4)

1 (1–4)

0.224

HBV DNA levels, log10 IU/mL, median (range)

7.73 (6.04~9.30)

7.72 (6.03~9.00)

0.858

HBV DNA levels > 108 IU/mL, n (%)

60 (43.2%)

45 (44.1%)

0.883

HBV DNA levels 107–108 IU/mL, n (%)

62 (44.6%)

36 (35.3%)

0.184

ALT level, U/L, median (range)

117 (56–1166)

164 (53–1025)

0.867

AST level, U/L, median (range)

112 (32–1061)

101 (35–539)

0.301

Elevated AST levels, n (%)

136 (97.8%)

101 (99.0%)

0.640

TBIL, μmol/L, median (range)

11 (4–125)

11 (3–96)

0.911

HBeAg positive, n (%)

126 (90.6%)

91 (89.2%)

0.714